Rolph Timothy — SEC Form 4 filings
SEC reporting owner CIK 1779479. 27 Form 4 filings on record with FilingPulse; latest filed 2025-12-09.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2024-03-15 to 2025-12-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 37 legs across 20 filings — 191,710 shares, $9,399,245 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 25,000 shares @ $55.04 ($1,376,000) in Akero Therapeutics, Inc., filed 2025-06-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) | Chief Scientific Officer | 27 | — | 37 legs · 191,710 sh · $9,399,245 | 69 |
Form 4 filings — Rolph Timothy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 238,339 · Disposition to issuer (D): 43,810 · Disposition to issuer (D): 3,421 (derivative) · Disposition to issuer (D): 5,032 (derivative) · Disposition to issuer (D): 2,328 (derivative) · Disposition to issuer (D): 56,579 (derivative) · +7 more | EDGAR |
| 2025-11-28 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 3,527 @ $28.35 · Option exercise (M): 43,064 @ $6.36 · Option exercise (M): 4,284 @ $21.09 · Option exercise (M): 2,796 @ $0.61 · Option exercise (M): 94,268 @ $0.61 · Option exercise (M): 4,739 @ $21.10 · +6 more | EDGAR |
| 2025-11-19 | 4 | Akero Therapeutics, Inc. (AKRO) | Gift (G): 37,100 @ $0 | EDGAR |
| 2025-10-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $28.35 · Sale (S): 11,463 @ $46.01 · Sale (S): 1,037 @ $46.82 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 553 @ $43.02 | EDGAR |
| 2025-09-10 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 7,044 @ $21.09 · Option exercise (M): 5,161 @ $6.36 · Option exercise (M): 295 @ $28.35 · Sale (S): 12,466 @ $44.17 · Sale (S): 34 @ $44.88 · Option exercise (M): 7,044 (derivative) @ $0 · +2 more | EDGAR |
| 2025-08-07 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $21.09 · Sale (S): 5,538 @ $49.06 · Sale (S): 6,962 @ $49.49 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-07-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $21.09 · Sale (S): 10,634 @ $50.93 · Sale (S): 1,825 @ $52.00 · Sale (S): 41 @ $52.62 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 890 @ $23.87 | EDGAR |
| 2025-06-20 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 1,129 @ $54.84 | EDGAR |
| 2025-06-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,358 @ $54.00 | EDGAR |
| 2025-06-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $21.10 · Sale (S): 9,350 @ $53.37 · Sale (S): 3,150 @ $53.84 · Option exercise (M): 24,611 @ $21.09 · Option exercise (M): 389 @ $21.10 · Sale (S): 25,000 @ $55.04 · +3 more | EDGAR |
| 2025-05-08 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $21.10 · Sale (S): 3,550 @ $42.26 · Sale (S): 8,650 @ $43.87 · Sale (S): 300 @ $44.50 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-04-28 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 6,250 @ $21.10 · Sale (S): 6,250 @ $41.03 · Option exercise (M): 2,566 (derivative) @ $0 · Option exercise (M): 3,684 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 6,250 @ $21.10 · Sale (S): 2,200 @ $35.36 · Sale (S): 3,750 @ $36.05 · Sale (S): 100 @ $36.93 · Sale (S): 200 @ $37.91 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 516 @ $44.88 | EDGAR |
| 2025-03-07 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 12,500 @ $21.10 · Sale (S): 9,338 @ $44.40 · Sale (S): 3,162 @ $44.90 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 18,750 @ $21.10 · Sale (S): 12,847 @ $56.33 · Sale (S): 5,903 @ $56.92 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 14,986 @ $19.87 · Option exercise (M): 16,264 @ $21.10 · Sale (S): 13,812 @ $54.76 · Sale (S): 5,059 @ $55.62 · Sale (S): 12,379 @ $56.97 · Option exercise (M): 14,986 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-10 | 4 | Akero Therapeutics, Inc. (AKRO) | Gift (G): 14,000 @ $0 | EDGAR |
| 2024-12-30 | 4 | Akero Therapeutics, Inc. (AKRO) | Gift (G): 14,100 @ $0 | EDGAR |
| 2024-12-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 3,800 @ $19.87 · Sale (S): 3,800 @ $31.10 · Grant/award (A): 20,000 @ $0 · Option exercise (M): 3,800 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,368 @ $30.79 · Option exercise (M): 2,450 @ $19.87 · Sale (S): 2,450 @ $31.03 · Option exercise (M): 2,450 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 537 @ $26.18 | EDGAR |
| 2024-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 1,064 @ $19.94 | EDGAR |
| 2024-06-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 2,380 @ $22.64 | EDGAR |
| 2024-03-15 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 619 @ $28.33 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1779479 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →